ArticleMolecular genetics & genomic medicine2026
A Novel Intronic Variant Causes Aberrant Splicing of PCDH15 in a Family With Usher Syndrome Type 1F.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Novel Intronic Variant Causes Aberrant Splicing of PCDH15 in a Family With Usher Syndrome Type 1F.Molecular genetics & genomic medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveVariants of the proto-cadherin 15 (PCDH15) gene are related to Usher syndrome type 1F (USH1F). The purpose of this study was to determine the genetic etiology of a USH1F family in China and to perform a minigene assay for the PCDH15 gene to explore the effect of variation on splicing and determine the pathogenicity of the identified variant.
methodsTargeted next-generation sequencing of 127 hearing loss-related genes was performed for a 26-year-old proband to identify the candidate variants. Then, multiplex ligation-dependent probe amplification (MLPA) and Sanger sequencing were performed for all family members to confirm the variants. Further, to verify the pathogenicity of the intronic variant, a minigene splicing assay was performed.
resultsCompound heterozygous PCDH15 EX1_2DEL and c.3717+5G>A variants were identified in the proband. MLPA and Sanger sequencing confirmed these two variants and showed the same genotype of a paternally inherited c.3717+5G>A and a maternally inherited EX1_2DEL variation in both the proband and his affected sister. The minigene assay verified the pathogenicity of c.3717+5G>A and indicated that this variant possibly caused abnormal splicing, resulting in jump of exon 27 and retention of 51 bp at the 5' end of intron 27, leading to the formation of abnormal proteins.
conclusionThis study reports a novel pathogenic variant c.3717+5G>A of PCDH15 in a proband for the first time. These findings offer evidence for the genetic counseling of USH1F. Minigene splicing assays are considered to be one of the most powerful methods for determining whether intron mutations lead to abnormal splicing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.